skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Astatine-211-tellurium radiocolloid cures experimental malignant ascites

Journal Article · · Science; (United States)

An investigation of the efficacy of astatine-211-tellurium colloid for the treatment of experimental malignant ascites in mice reveals that this ..cap alpha..-emitting radiocolloid can be curative without causing undue toxicity to normal tissue. By comparison, negatron-emitting phosphorus-32 as colloidal chromic phosphate had no antineoplastic activity. The most compelling explanation for this striking difference is the dense ionization and short range of action associated with ..cap alpha..-emission. These results have important implications for the development and use of ..cap alpha..-emitters as radiocolloid therapy for the treatment of human tumors.

DOE Contract Number:
EY-76-S-4115; AC02-76CH0016
OSTI ID:
6550586
Journal Information:
Science; (United States), Vol. 212:4492
Country of Publication:
United States
Language:
English